HIV Lecture in Houston - July 12

Open to patients and clinicians

Date: Wednesday, July 12

Time : 6:30 pm - 8:30 pm

Place: Lovett Inn ( http://www.lovettinn.com/main.php )

Speakers: Dr Shannon Schrader and Nelson Vergel


TOPICS:

1- Updated review of HIV pipeline products

2- How to best maximize the effects of Prezista, the newly approved protease inhibitor for multi-protease resistant virus

3- What is virtual monotherapy and what are its risks?

4- What are the best predictors of treatment response in patients with multidrug resistant virus?

5- Information on Fuzeon's needle free injection device (BOSS Study)

6- Integrase Inhibitors- Why the hype?

7- Are oral entry inhibitors safe and effective? What do the studies so far show?

8- Gene therapy in HIV- An update

9- Questions and Answers

Reply to this email or nelsonvergel@yahoo.com to reserve a seat since space is very limited.

For those who cannot attend, there will be a live chat at thebody.com on July 10th at 2:30 pm Central. Questions can be sent in now. A full transcript will be available after the chat. For more information:
http://www.thebody.com/submit/?/chat/main_071006.html